화일약품

061250KOSDAQ

49.5 / 100

Reference Date: 2026-10-23

Financial Score20.0 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 14.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Hwa-il Pharm Co., Ltd. is a company engaged in the production and sale of pharmaceutical raw materials, finished pharmaceuticals, and functional health food ingredients, with three domestic production facilities and an expansion plan for the Pyeongtaek plant. The business is accelerating growth due to the expansion of the generic drug market and increased demand for antibiotics, with sales reaching 100.8 billion KRW in 2025.

Number of Employees

145people

Average Salary

61.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.25Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-0.11Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

0.13Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼9.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼232.5% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 1.8% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position5.0Point

52w mid range (59%)

Current 6,050Won52-week high 9,53052-week low 918

1-month return1.0Point

1m -14.67% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral증권발행결과(자율공시)2026-10-08
Neutral[기재정정]주요사항보고서(전환사채권발행결정)2026-10-02